©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Sep 27, 2022; 14(9): 1778-1789
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1778
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1778
Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
Yin Lai, Jin-Chiao Lee, Hao-Chien Hung, Yu-Chao Wang, Chih-Hsien Cheng, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee, Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan 333, Taiwan
Chen-Yao Kao, Department of Special Education, National University of Tainan, Tainan 700, Taiwan
Author contributions: Lai Y designed and performed the research and wrote the paper; Hung HC and Lee JC contributed to the analysis; Wang YC, Cheng CH, Wu TH, Lee CF, Wu TJ, Chou HS, and Chan KM provided clinical advice; Kao CY contributed to the final manuscript; Lee WC supervised the report.
Institutional review board statement: This study was approved by the local ethics committee of Chang Gung Memorial Hospital, No. 104-3900B.
Informed consent statement: Because of retrospective study, signed informed consent form is not needed. However, Chang-Gung Memorial Hospital has given permission to conduct this study.
Conflict-of-interest statement: The authors declare that there are no conflict of interests.
Data sharing statement: The data that support the findings of this study are available from the corresponding author, Lee WC, upon reasonable request.
Corresponding author: Wei-Chen Lee, MD, Professor, Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, No. 5 Fu-Hsing Street, Kwei-Shan, Taoyuan 333, Taiwan. weichen@cgmh.org.tw
Received: January 12, 2022
Peer-review started: January 12, 2022
First decision: April 16, 2022
Revised: April 30, 2022
Accepted: August 22, 2022
Article in press: August 22, 2022
Published online: September 27, 2022
Processing time: 253 Days and 9.8 Hours
Peer-review started: January 12, 2022
First decision: April 16, 2022
Revised: April 30, 2022
Accepted: August 22, 2022
Article in press: August 22, 2022
Published online: September 27, 2022
Processing time: 253 Days and 9.8 Hours
Core Tip
Core Tip: This retrospective study recruited over 1000 patients and developed a simple preoperative score to evaluate the recurrence risk of hepatocellular carcinoma after surgical resection. Despite the lack of pathological features, predictive power was satisfactory. Appropriate treatment can be planned preoperatively by dividing patients into risk groups.